The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma

被引：0
|
作者：
W Wu
K Merriman
A Nabaah
N Seval
D Seval
H Lin
M Wang
M H Qazilbash
V Baladandayuthapani
D Berry
R Z Orlowski
M-H Lee
S-C J Yeung
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Emergency Medicine
[2] Zhongshan Hospital,Department of Biostatistics
[3] Xiamen University,Department of Lymphoma and Myeloma
[4] The University of Texas MD Anderson Cancer Center,Department of Stem Cell Transplantation
[5] The University of Texas MD Anderson Cancer Center,Department of Experimental Therapeutics
[6] The University of Texas MD Anderson Cancer Center,Department of Molecular and Cellular Oncology
[7] The University of Texas MD Anderson Cancer Center,Department of Endocrine Neoplasia and Hormonal Disorders
[8] The University of Texas MD Anderson Cancer Center,undefined
[9] The University of Texas MD Anderson Cancer Center,undefined
来源：
British Journal of Cancer | 2014年 / 111卷
关键词：
steroid-induced diabetes; myeloma; survival; prognosis; insulin; metformin; pharmaco-epidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：628 / 636
页数：8
相关论文
共 50 条
  • [1] The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma
    Wu, W.
    Merriman, K.
    Nabaah, A.
    Seval, N.
    Seval, D.
    Lin, H.
    Wang, M.
    Qazilbash, M. H.
    Baladandayuthapani, V.
    Berry, D.
    Orlowski, R. Z.
    Lee, M-H
    Yeung, S-C J.
    BRITISH JOURNAL OF CANCER, 2014, 111 (03) : 628 - 636
  • [2] Prescription patterns of anti-diabetic medications and clinical outcomes in Asian patients with heart failure and diabetes mellitus
    Chia, Yvonne M. F.
    Teng, Tiew-Hwa K.
    Tay, Wan T.
    Anand, Inder
    MacDonald, Michael R.
    Yap, Jonathan
    Chandramouli, Chanchal
    Richards, A. Mark
    Tromp, Jasper
    Ouwerkerk, Wouter
    Ling, Lieng H.
    Lam, Carolyn S. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (05) : 685 - +
  • [3] Diabetes, duration of diabetes, use of anti-diabetic medications, and risk of hepatocellular carcinoma
    Simon, Tracey G.
    King, Lindsay Y.
    Chong, Dawn Q.
    Ma, Yanan
    Khalili, Hamed
    Chung, Raymond T.
    Zhang, Xuehong
    Chan, Andrew T.
    HEPATOLOGY, 2017, 66 : 759A - 760A
  • [4] Ethiopian patients' perceptions of anti-diabetic medications: Implications for diabetes education
    Habte B.M.
    Kebede T.
    Fenta T.G.
    Boon H.
    Journal of Pharmaceutical Policy and Practice, 10 (1)
  • [5] Cardiovascular Effects of Anti-Diabetic Medications in Type 2 Diabetes Mellitus
    Singh, Samar
    Bhat, Jyoti
    Wang, Ping H.
    CURRENT CARDIOLOGY REPORTS, 2013, 15 (01)
  • [6] Cardiovascular Effects of Anti-Diabetic Medications in Type 2 Diabetes Mellitus
    Samar Singh
    Jyoti Bhat
    Ping H. Wang
    Current Cardiology Reports, 2013, 15
  • [7] Anti-diabetic medications in relation to dementia
    Cheng, Chin
    ASIA-PACIFIC PSYCHIATRY, 2012, 4 : 82 - 82
  • [8] Influence of anti-diabetic medications on the outcomes of patients with pancreatic ductal adenocarcinoma and type 2 diabetes mellitus
    Pretta, A.
    Pinna, G.
    Donisi, C.
    Persano, M.
    Cimbro, E.
    Parrino, A.
    Migliari, M.
    Dubois, M.
    Liscia, N.
    Mariani, S.
    Lai, E.
    Pusceddu, V.
    Puzzoni, M.
    Ziranu, P.
    Scartozzi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S142 - S142
  • [9] Effect of Anti-Diabetic Medications on Fracture Risk in Type II Diabetes Mellitus
    Lahoud, Youmna
    Peloquin, Christine
    Zhang, Yuqing
    Misra, Devyani
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [10] Attenuation of Endothelial Dysfunction in Diabetes Mellitus: An Integral Characteristic of Anti-Diabetic Medications
    Ugwueze, Chidiebere V.
    JOURNAL OF DIABETOLOGY, 2025, 16 (01) : 1 - 13
12345